Antheia lands $80M conditional loan from Trump administration to onshore drug manufacturing

Next-gen manufacturer Antheia is teaming up with the U.S. Department of War to build out its infrastructure and onshore the U.S. drug supply chain.
Antheia gets $80M conditional DOD loan to onshore to the US

Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs.
Brewing beer, drug ingredients, and making the US supply chain more resilient

Proponents say using fermentation processes can help reduce America’s reliance on China and India for key starting materials and active pharmaceutical ingredients.